The Revised International Staging System Compared to the Classical International Staging System Better Discriminates Risk Groups among Transplant-Ineligible Multiple Myeloma Patients

Publisher： Karger

E-ISSN： 2296-5262|40|10|616-620

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.40, Iss.10, 2017-09, pp. : 616-620

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Is the revised International staging system for myeloma valid in a real world population?

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 180, Iss. 3, 2018-02 ,pp. : 451-454

John Wiley & Sons Inc

Access to resources Recommend Favorite

Risk Stratification Model in Elderly Patients with Multiple Myeloma: Clinical Role of Magnetic Resonance Imaging Combined with International Staging System and Cytogenetic Abnormalities

By  

Acta Haematologica, Vol. 134, Iss. 1, 2015-03 ,pp. : 7-16

Karger

Access to resources Recommend Favorite

A new staging system to predict prognosis of patients with multiple myeloma in an era of novel therapeutic agents

By  

EUROPEAN JOURNAL OF HAEMATOLOGY, Vol. 94, Iss. 2, 2015-02 ,pp. : 145-151

John Wiley & Sons Inc

Access to resources Recommend Favorite

Realistic Lenalidomide Dose Adjustment Strategy for Transplant-Ineligible Elderly Patients with Relapsed/Refractory Multiple Myeloma: Japanese Real-World Experience

By  

Acta Haematologica, Vol. 138, Iss. 1, 2017-07 ,pp. : 55-60

Karger

Access to resources Recommend Favorite

Validation of the Revised International Prognostic Scoring System for Patients with Myelodysplastic Syndromes

By  

Acta Haematologica, Vol. 131, Iss. 4, 2013-12 ,pp. : 231-238

Karger

Access to resources Recommend Favorite